Literature DB >> 13955156

Prevalence of Actin-omyces israelii, A. naeslundii, Bacterionema matruchotii, and Candida albicans in selected areas of the oral cavity and saliva.

A HOWELL, R M STEPHAN, F PAUL.   

Abstract

Entities:  

Keywords:  ACTINOMYCES; CANDIDA; LEPTOTHRIX; MOUTH; SALIVA

Mesh:

Substances:

Year:  1962        PMID: 13955156     DOI: 10.1177/00220345620410050701

Source DB:  PubMed          Journal:  J Dent Res        ISSN: 0022-0345            Impact factor:   6.116


× No keyword cloud information.
  8 in total

1.  IDENTIFICATION OF SPECIES OF ACTINOMYCES.

Authors:  L K GEORG; G W ROBERTSTAD; S A BRINKMAN
Journal:  J Bacteriol       Date:  1964-08       Impact factor: 3.490

2.  Isolation of Bacillary and Streptococcal Variants from Bacterionema matruchotii.

Authors:  J L Streckfuss; W N Smith
Journal:  J Bacteriol       Date:  1970-12       Impact factor: 3.490

3.  Characterization of a dextranase produced by an oral strain of Actinomyces israelii.

Authors:  R H Staat; C F Schachtele
Journal:  Infect Immun       Date:  1975-09       Impact factor: 3.441

4.  Epidemiological investigations or oral Candida albicans.

Authors:  J A Schmitt
Journal:  Mycopathol Mycol Appl       Date:  1971-01-25

5.  Actinomyces naeslundii as an agent of pelvic actinomycosis in the presence of an intrauterine device.

Authors:  W Bonnez; G Lattimer; N A Mohanraj; T H Johnson
Journal:  J Clin Microbiol       Date:  1985-02       Impact factor: 5.948

6.  Development of a selective medium for detection and enumeration of Actinomyces viscosus and Actinomyces naeslundii in dental plaque.

Authors:  L J Zylber; H V Jordan
Journal:  J Clin Microbiol       Date:  1982-02       Impact factor: 5.948

7.  Nonsporing, anaerobic, gram-positive rods in saliva and the gingival crevice of humans.

Authors:  B Sanyal; C Russell
Journal:  Appl Environ Microbiol       Date:  1978-04       Impact factor: 4.792

8.  Attachment of Actinomyces naeslundii to human buccal epithelial cells.

Authors:  J M Saunders; C H Miller
Journal:  Infect Immun       Date:  1980-09       Impact factor: 3.441

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.